Cargando…
Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
Autores principales: | Riker, Richard R., May, Teresa L., Fraser, Gilles L., Gagnon, David J., Bandara, Mahesh, Zemrak, Wes, Seder, David B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361545/ https://www.ncbi.nlm.nih.gov/pubmed/32838110 http://dx.doi.org/10.1002/rth2.12417 |
Ejemplares similares
-
Heparin‐induced thrombocytopenia with thrombosis in COVID‐19 adult respiratory distress syndrome
por: Riker, Richard R., et al.
Publicado: (2020) -
The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
por: May, Jori E., et al.
Publicado: (2020) -
Heparin induced thrombocytopenia-type 2
por: Majeed, Tanveer A.
Publicado: (2010) -
Re: Heparin-induced thrombocytopenia – Type 2
por: Yagnik, Vipul D.
Publicado: (2011) -
Heparin-induced thrombocytopenia in a patient with colon cancer
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)